Company profile
ETHRIS company profile
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.
Business identity
- Website
- http://ethris.com/
- Contact email
- [email protected]
- Phone number
- +4908989557880
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $0+
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Planegg, Bavaria, Germany
- Postal code
- 82152
- Country code
- DE
- Continent
- Europe